Raymond James Financial Services Advisors
WGS icon

Raymond James Financial Services Advisors’s GeneDx Holdings WGS Stock Holding History

Raymond James Financial Services Advisors’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8,609
Closed -$225K – 3568
2024
Q2 		$225K Buy
+8,609
New +$163K ﹤0.01% 3044

Other funds holding WGS

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Corvex Management
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return

Raymond James Financial Services Advisors's WGS Position: Q3 2024 in Review

Raymond James Financial Services Advisors sold out of GeneDx Holdings (WGS) in Q3 2024, closing a stake of 8,609 shares — an estimated $225K sold.

Raymond James Financial Services Advisors first reported a position in WGS in Q2 2024 and held it in 1 quarter. The position peaked at $225K in Q2 2024. 136 funds tracked by Wall St. Rank hold WGS as of Q3 2024.

  • Raymond James Financial Services Advisors reported no remaining GeneDx Holdings position as of Q3 2024 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 8,609 GeneDx Holdings shares in Q3 2024, an estimated $225K.
  • Raymond James Financial Services Advisors first reported a position in GeneDx Holdings in Q2 2024 and held it in 1 quarter.
  • Raymond James Financial Services Advisors's GeneDx Holdings position peaked at $225K in Q2 2024.
  • 136 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.